Study of the MDM2 -410T-G polymorphism (rs2279744) by pyrosequencing in mothers of Down Syndrome subjects

Springer Science and Business Media LLC - Tập 33 - Trang 476-478 - 2020
Michele Salemi1, Maria Grazia Salluzzo2, Concetta Barone3, Corrado Romano1
1Oasi Research Institute-IRCCS, Troina, Italy
2Oasi Research Institute – IRCCS, Troina, Italy
3Oasi Research Institute - IRCCS, Troina, Italy

Tóm tắt

Trisomy 21 or Down syndrome (DS) is the most frequent genetic etiology of intellectual disability in humans. MDM2 gene expression has a potential role as a risk factor for human aneuploidy. -410T-G (rs2279744) functional polymorphism in MDM2 gene impacts on the mechanisms of chromosomal non-disjunction. We analyzed, within a case–control study, such polymorphism in mothers of subjects with DS. Nucleotide polymorphism was detected by pyrosequencing technology. The distribution of MDM2-410T-G polymorphism showed no significant difference among mothers of subjects with DS and controls. Our results suggest that MDM2 -410T-G polymorphism is not a risk factor for DS in mothers.

Tài liệu tham khảo

Hassold T, Jacobs P. Trisomy in man. Ann Rev Genet. 1984;18:69–97. Antonarakis SE. Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group. N Engl J Med. 1991;324:872–6. Bond GL, Hu W, Bond EE, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 2004;119:591–602. Thompson SL, Compton DA. Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol. 2010;188:369–81. Salemi M, Salluzzo MG, Calogero AE, et al. Association study of COX-2 (PTGS2) -765 G/C promoter polymorphism by pyrosequencing in Sicilian patients with Alzheimer's disease. Arch Med Sci. 2014;22:1235–8. Salemi M, Barone C, Salluzzo MG, et al. A polymorphism (rs1042522) in TP53 gene is a risk factor for down syndrome in Sicilian mothers. J Matern Fetal Neonatal Med. 2016;7:1–3. Boquett JA, Brandalize AP, Fraga LR, et al. Maternal SNPs in the p53 pathway: risk factors for trisomy 21? Dis Markers. 2013;34:41–9. Dumont P, Leu JI, Della Pietra AC III, et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet. 2003;33:357–65. Thomas M, Kalita A, Labrecque S, et al. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol. 1999;19:1092–100. Hu W. The role of p53 gene family in reproduction. Cold Spring Harb Perspect Biol. 2009;2009:a001073. Zhang J, Zhang Y, Zhang Z. Association of rs2279744 and rs117039649 promoterpolymorphism with the risk of gynecological cancer: A meta-analysis of case-control studies. Med (Baltim). 2018;97(2):e9554.